Quick Answer
Burning Rock Biotech Ltd reported Operating Income Loss of -$357.56 million for the year ending 2024.
- Burning Rock Biotech Ltd showed an increase of +46.6% in Operating Income Loss from 2023 to 2024.
- This data is from Burning Rock Biotech Ltd's annual report (Form 10-K), filed with the SEC on April 29, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), Burning Rock Biotech Ltd's Operating Income Loss has declined by 121.5%.
- Historical annual values: Fiscal year 2024: -$357.56 million | Fiscal year 2023: -$669.32 million | Fiscal year 2022: -$980.41 million | Fiscal year 2021: -$797.06 million | Fiscal year 2020: -$412.41 million | Fiscal year 2019: -$169.09 million | Fiscal year 2018: -$161.40 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: